FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Yu Li 2. Date of Event Requiring Statement (MM/DD/YYYY)
5/18/2021 

3. Issuer Name and Ticker or Trading Symbol OncoCyte Corp [OCX]
(Last)       (First)       (Middle)
15 CUSHING
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
VP Cntrllr/Prncpl Acctng Offcr /
(Street)
IRVINE, CA 92618      
(City)             (State)             (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units   (1)  (1) Common Stock  25000   (2) D   

Explanation of Responses:
(1)  The restricted stock units shall vest upon the completion of one year of continuous service from the date of grant.
(2)  Grant of restricted stock units under the OncoCyte 2018 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Common Stock.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Yu Li
15 CUSHING
IRVINE, CA 92618


VP Cntrllr/Prncpl Acctng Offcr

Signatures
/s/ Li Yu 5/24/2021
**Signature of Reporting Person Date
Oncocyte (NASDAQ:OCX)
Historical Stock Chart
From Jul 2021 to Aug 2021 Click Here for more Oncocyte Charts.
Oncocyte (NASDAQ:OCX)
Historical Stock Chart
From Aug 2020 to Aug 2021 Click Here for more Oncocyte Charts.